Utilisation de SYMLIN chez les patients diabétiques de type 2 et de type 1 utilisant de l'insuline

Date de début de l'étude : 1 septembre 2005

Inclusion Criteria: * The following inclusion criteria are consistent with information in the SYMLIN package insert and apply to insulin using patients with type 2 or type 1 diabetes who: * Have failed to achieve the desired or optimal level of glycemic control despite utilizing appropriate, individualized insulin regimens * Have A1C \<=9.0% within 3 months of study enrollment * Are receiving ongoing diabetes care under the guidance of a Health Care Provider (HCP) trained in the use of SYMLIN Exclusion Criteria: * The following exclusion criteria are consistent with the SYMLIN package insert and specifically exclude patients who: * Are poorly compliant with their current insulin regimen, as defined by their HCP * Are poorly compliant with prescribed blood glucose self monitoring, as defined by their HCP * Have experienced recurrent patient-ascertained severe hypoglycemia requiring assistance during the past 6 months * Have hypoglycemia unawareness * Have a confirmed diagnosis of gastroparesis * Require the use of drugs that stimulate gastrointestinal motility * Are female and pregnant or lactating and for whom the HCP determines the potential benefit does not justify the potential risk to the fetus or infant * Have been treated with SYMLIN within 3 months prior to study start